'Questions About Quitting' Smoking Cessation Trial (Q2)
|ClinicalTrials.gov Identifier: NCT00992264|
Recruitment Status : Completed
First Posted : October 9, 2009
Results First Posted : August 15, 2014
Last Update Posted : October 13, 2017
|Condition or disease||Intervention/treatment||Phase|
|Smoking||Behavioral: Message Tone Behavioral: Navigation Behavioral: Proactive Outreach Behavioral: Testimonials||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1865 participants|
|Intervention Model:||Factorial Assignment|
|Official Title:||Optimizing an Online Motivational Tobacco Cessation Program|
|Study Start Date :||May 2010|
|Actual Primary Completion Date :||November 2012|
|Actual Study Completion Date :||November 2013|
Experimental: Message Tone
Prescriptive or Motivational
Persons are randomized to receive intervention content written in either a prescriptive or motivational tone.
Behavioral: Message Tone
All participants receive an tailored, online smoking cessation program. Participants in this intervention group either receive content written in a prescriptive tone or a motivational tone.
Persons are randomized to receive a personally tailored testimonial or not.
People receive a personally-tailored testimonial as part of their online smoking cessation program.
Dictated or Non-Dictated
Persons are randomly assigned to be able to freely navigate the website or to have their navigation of the website pre-determined based on their baseline readiness to quit smoking.
Persons in this arm either have their ability to navigate the site dictated for them based on their readiness to quit smoking or they are able to freely navigate through the website.
Experimental: Proactive Outreach
Email or No-Email communication
Persons are randomized to receive periodic email reminders to return to the intervention website or not.
Behavioral: Proactive Outreach
Persons receive periodic, proactively delivered email reminders to visit the intervention website.
- Smoking Abstinence [ Time Frame: 12 months ]7 day point prevalent abstinence
- Treatment Utilization for Smoking Cessation [ Time Frame: 12 months ]confirmed use of pharmacotherapy or enrollment in health plan-sponsored counseling program
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00992264
|United States, Washington|
|Group Health Research Institute|
|Seattle, Washington, United States, 98101|
|Principal Investigator:||Jennifer B McClure, PhD||Group Health Research Institute|